2020
DOI: 10.1055/a-1143-2825
|View full text |Cite
|
Sign up to set email alerts
|

Hyperfibrinolyse nach Reanimation bei akuter Lungenarterienembolie

Abstract: ZusammenfassungKommt es nach einer Reanimation – z. B. wegen akuter Lungenarterienembolie – im Rahmen eines Post-Cardiac-Arrest-Syndroms (PCAS) zu einer Hyperfibrinolyse, stellt dies eine diagnostische und therapeutische Herausforderung dar. In diesem Fallbericht wird die Pathophysiologie der Koagulopathie bei PCAS beschrieben und der Einsatz antifibrinolytischer Therapie bei Patienten mit thrombotischen Komplikationen wie Lungenarterienembolien diskutiert.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Patients with high levels of PA are at a risk of systemic fibrinolysis and bleeding [7,8]. Hyperfibrinolysis is therefore one of the most common and important causes of massive blood loss in clinical practice [9,10]. Tranexamic acid (TXA), as a lysine analogue widely available in nature, is found to be an appropriate hemostatic drug.…”
Section: Introductionmentioning
confidence: 99%
“…Patients with high levels of PA are at a risk of systemic fibrinolysis and bleeding [7,8]. Hyperfibrinolysis is therefore one of the most common and important causes of massive blood loss in clinical practice [9,10]. Tranexamic acid (TXA), as a lysine analogue widely available in nature, is found to be an appropriate hemostatic drug.…”
Section: Introductionmentioning
confidence: 99%